ArticleChemistry (Weinheim an der Bergstrasse, Germany)2021
Chiral-at-Iron Catalyst for Highly Enantioselective and Diastereoselective Hetero-Diels-Alder Reaction.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Imidazol-2-ylidene-Based NCCN Ligands for Chiral-at-Iron Catalysis.Organometallics · 2026Article
- Hot-Carrier Injection and Millisecond Charge Separation from a Robust Heteroleptic Iron(II) Chromophore Immobilized on TiOJournal of the American Chemical Society · 2026Article
- An Achiral Tetradentate Cis-α-Coordinating NCCN Ligand Gives Rise to a Configurationally Stable Chiral-at-Iron Complex for Enantioselective Catalysis.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026Article
- Chiral-at-Tungsten Dioxo Complexes─A Computational Study on Inhibiting Racemization.Inorganic chemistry · 2025Article
- Chiral-at-metal catalysts: history, terminology, design, synthesis, and applications.Chemical Society reviews · 2025Review
- Beyond the First Coordination Sphere─Manipulating the Excited-State Landscape in Iron(II) Chromophores with Protons.Journal of the American Chemical Society · 2024Article
- IronChemical science · 2024Article
- Metal Stereogenicity in Asymmetric Transition Metal Catalysis.Chemical reviews · 2023Review
- Improving the Configurational Stability of Chiral-at-Iron Catalysts Containing TwoOrganometallics · 2022Article
- Racemization Pathway for MoOInorganic chemistry · 2022Article
- Enantioselective Organocopper-Catalyzed Hetero Diels-Alder Reaction throughJournal of the American Chemical Society · 2022Article
- Recent Development of Bis-Cyclometalated Chiral-at-Iridium and Rhodium Complexes for Asymmetric Catalysis.ACS organic & inorganic Au · 2022Review
- Chiral-at-Iron Catalyst for Highly Enantioselective and Diastereoselective Hetero-Diels-Alder Reaction.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study demonstrates that chiral-at-iron complexes, in which all coordinated ligands are achiral and the overall chirality the consequence of a stereogenic iron center, are capable of catalyzing asymmetric transformations with very high enantioselectivities. The catalyst is based on a previously reported design (J. Am. Chem. Soc. 2017, 139, 4322), in which iron(II) is surrounded by two configurationally inert achiral bidentate N-(2-pyridyl)-substituted N-heterocyclic carbenes in a C
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.